Vault-13

TCG Crossover Management, LLC

PALO ALTO, CA · CIK 1839948 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$4.2bn reported value +19.0% vs Q1 2026
54positions
57.4%in top 10
12 new 2 added 9 reduced 7 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ABIVAX SA SPONSORED ADS ABVX ABVX 6,007,834 $800.6m19.24% 19.24% ReducedShares held: Q3 2025 7.1m, Q4 2025 7.1m, Q1 2026 6.5m, Q2 2026 6.0m -473.3k -473,251 -7.3%
2 TANGO THERAPEUTICS INC COM TNGX TNGX 9,081,201 $283.9m6.82% 6.82% ReducedShares held: Q3 2025 8.5m, Q4 2025 12.8m, Q1 2026 10.5m, Q2 2026 9.1m -1.4m -1,449,870 -13.8%
3 CG ONCOLOGY INC COM CGON CGON 3,670,206 $260.8m6.27% 6.27% UnchangedShares held: Q3 2025 3.7m, Q4 2025 3.7m, Q1 2026 3.7m, Q2 2026 3.7m
4 COGENT BIOSCIENCES INC COM COGT COGT 4,854,436 $187.9m4.52% 4.52% ReducedShares held: Q3 2025 6.8m, Q4 2025 5.9m, Q1 2026 4.9m, Q2 2026 4.9m -92.5k -92,458 -1.9%
5 IMMUNOVANT INC COM IMVT IMVT 4,457,988 $171.8m4.13% 4.13% UnchangedShares held: Q3 2025 0, Q4 2025 1.7m, Q1 2026 4.5m, Q2 2026 4.5m
6 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 1,900,582 $168.7m4.06% 4.06% UnchangedShares held: Q3 2025 1.1m, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
7 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,676,624 $163.4m3.93% 3.93% UnchangedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 1.7m, Q2 2026 1.7m
8 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 1,062,049 $124.3m2.99% 2.99% UnchangedShares held: Q3 2025 0, Q4 2025 62.0k, Q1 2026 1.1m, Q2 2026 1.1m
9 ZAI LAB LTD ADR ZLAB ZLAB 6,137,627 $116.6m2.80% 2.80% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.1m
10 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 6,243,812 $112.1m2.70% 2.70% UnchangedShares held: Q3 2025 6.2m, Q4 2025 6.2m, Q1 2026 6.2m, Q2 2026 6.2m
11 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 4,622,151 $111.9m2.69% 2.69% UnchangedShares held: Q3 2025 0, Q4 2025 4.6m, Q1 2026 4.6m, Q2 2026 4.6m
12 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 11,020,968 $110.2m2.65% 2.65% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 11.0m, Q2 2026 11.0m
13 VOR BIOPHARMA INC COM NEW VOR VOR 5,673,078 $104.4m2.51% 2.51% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.7m, Q2 2026 5.7m
14 TYRA BIOSCIENCES INC COM TYRA TYRA 3,248,980 $103.8m2.49% 2.49% UnchangedShares held: Q3 2025 2.9m, Q4 2025 2.9m, Q1 2026 3.2m, Q2 2026 3.2m
15 DYNE THERAPEUTICS INC COM DYN DYN 4,615,144 $102.5m2.46% 2.46% UnchangedShares held: Q3 2025 4.6m, Q4 2025 4.6m, Q1 2026 4.6m, Q2 2026 4.6m
16 DISC MEDICINE INC COM IRON IRON 1,341,862 $98.1m2.36% 2.36% UnchangedShares held: Q3 2025 465.3k, Q4 2025 0, Q1 2026 1.3m, Q2 2026 1.3m
17 RELAY THERAPEUTICS INC COM RLAY RLAY 4,273,356 $80.0m1.92% 1.92% UnchangedShares held: Q3 2025 1.8m, Q4 2025 3.2m, Q1 2026 4.3m, Q2 2026 4.3m
18 SAVARA INC COM SVRA SVRA 12,362,205 $76.2m1.83% 1.83% UnchangedShares held: Q3 2025 12.4m, Q4 2025 12.4m, Q1 2026 12.4m, Q2 2026 12.4m
19 AURA BIOSCIENCES INC COM AURA AURA 9,533,333 $67.7m1.63% 1.63% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.5m
20 REVOLUTION MEDICINES INC COM RVMD RVMD 340,899 $63.8m1.53% 1.53% ReducedShares held: Q3 2025 436.5k, Q4 2025 436.5k, Q1 2026 576.5k, Q2 2026 340.9k -235.6k -235,574 -40.9%
21 FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX TRAX 2,895,304 $58.3m1.40% 1.40% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.9m
22 KODIAK SCIENCES INC COM KOD KOD 1,445,538 $56.3m1.35% 1.35% UnchangedShares held: Q3 2025 1.1m, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 1.4m
23 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 3,017,120 $55.8m1.34% 1.34% AddedShares held: Q3 2025 483.0k, Q4 2025 483.0k, Q1 2026 738.4k, Q2 2026 3.0m +2.3m +2,278,737 308.6%
24 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 1,447,310 $47.0m1.13% 1.13% ReducedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 1.8m, Q2 2026 1.4m -392.2k -392,179 -21.3%
25 CENTURY THERAPEUTICS INC COM IPSC IPSC 17,754,430 $43.4m1.04% 1.04% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 17.8m, Q2 2026 17.8m
26 TECTONIC THERAPEUTIC INC COM TECX TECX 1,204,891 $41.4m1.00% 1.00% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.2m
27 XENCOR INC COM XNCR XNCR 2,452,138 $39.5m0.95% 0.95% UnchangedShares held: Q3 2025 2.5m, Q4 2025 2.5m, Q1 2026 2.5m, Q2 2026 2.5m
28 SURROZEN INC COM NEW SRZN SRZN 1,473,101 $38.2m0.92% 0.92% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 1.5m
29 EDITAS MEDICINE INC COM EDIT EDIT 11,111,111 $36.0m0.87% 0.87% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 11.1m
30 MBX BIOSCIENCES INC COM MBX MBX 650,000 $35.9m0.86% 0.86% UnchangedShares held: Q3 2025 650.0k, Q4 2025 650.0k, Q1 2026 650.0k, Q2 2026 650.0k
31 PHARVARIS N V COM PHVS PHVS 1,008,229 $34.9m0.84% 0.84% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
32 SILENCE THERAPEUTICS PLC ADS SLN SLN 3,033,560 $33.3m0.80% 0.80% UnchangedShares held: Q3 2025 3.0m, Q4 2025 3.0m, Q1 2026 3.0m, Q2 2026 3.0m
33 INFLARX NV COM IFRX IFRX 14,500,000 $32.5m0.78% 0.78% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.5m
34 ALTIMMUNE INC COM NEW ALT ALT 10,000,000 $30.4m0.73% 0.73% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.0m
35 JANUX THERAPEUTICS INC COM JANX JANX 1,789,617 $27.5m0.66% 0.66% UnchangedShares held: Q3 2025 0, Q4 2025 1.8m, Q1 2026 1.8m, Q2 2026 1.8m
36 PERSPECTIVE THERAPEUTICS INC COM NEW CATX CATX 7,915,567 $27.0m0.65% 0.65% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 7.9m, Q2 2026 7.9m
37 AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB AGMB 2,053,233 $26.7m0.64% 0.64% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.1m, Q2 2026 2.1m
38 BIOHAVEN LTD COM BHVN BHVN 1,779,952 $26.5m0.64% 0.64% ReducedShares held: Q3 2025 0, Q4 2025 4.6m, Q1 2026 4.6m, Q2 2026 1.8m -2.9m -2,851,365 -61.6%
39 AKTIS ONCOLOGY INC COM AKTS AKTS 696,560 $22.5m0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 696.6k
40 ALECTOR INC COM ALEC ALEC 10,000,000 $20.1m0.48% 0.48% UnchangedShares held: Q3 2025 0, Q4 2025 10.0m, Q1 2026 10.0m, Q2 2026 10.0m
41 FORTE BIOSCIENCES INC COM NEW FBRX FBRX 920,000 $19.6m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 920.0k
42 MONOPAR THERAPEUTICS INC COM NEW MNPR MNPR 203,327 $18.8m0.45% 0.45% AddedShares held: Q3 2025 153.0k, Q4 2025 141.9k, Q1 2026 132.1k, Q2 2026 203.3k +71.2k +71,224 53.9%
43 OCULAR THERAPEUTIX INC COM OCUL OCUL 1,647,752 $16.2m0.39% 0.39% UnchangedShares held: Q3 2025 6.1m, Q4 2025 5.7m, Q1 2026 1.6m, Q2 2026 1.6m
44 ADC THERAPEUTICS SA SHS ADCT ADCT 11,390,175 $12.2m0.29% 0.29% UnchangedShares held: Q3 2025 1.4m, Q4 2025 11.4m, Q1 2026 11.4m, Q2 2026 11.4m
45 ALX ONCOLOGY HLDGS INC COM ALXO ALXO 5,655,487 $11.7m0.28% 0.28% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 13.0m, Q2 2026 5.7m -7.4m -7,356,362 -56.5%
46 ENTRADA THERAPEUTICS INC COM TRDA TRDA 1,060,230 $7.8m0.19% 0.19% ReducedShares held: Q3 2025 585.0k, Q4 2025 2.1m, Q1 2026 2.3m, Q2 2026 1.1m -1.2m -1,227,270 -53.6%
47 CULLINAN THERAPEUTICS INC COM CGEM CGEM 406,786 $7.4m0.18% 0.18% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 406.8k, Q2 2026 406.8k
48 ARVINAS INC COM ARVN ARVN 707,098 $5.9m0.14% 0.14% ReducedShares held: Q3 2025 1.6m, Q4 2025 2.7m, Q1 2026 2.4m, Q2 2026 707.1k -1.7m -1,680,363 -70.4%
49 KORRO BIO INC COM KRRO KRRO 416,301 $5.5m0.13% 0.13% UnchangedShares held: Q3 2025 416.3k, Q4 2025 416.3k, Q1 2026 416.3k, Q2 2026 416.3k
50 RESEARCH ALLIANCE CORP III ORD SHS CL A RACC RACC 500,000 $5.3m0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
51 LEONABIO INC COM LONA LONA 464,398 $4.3m0.10% 0.10% UnchangedShares held: Q3 2025 0, Q4 2025 464.4k, Q1 2026 464.4k, Q2 2026 464.4k
52 JATT II ACQUISITION CORP ORD SHS JATT JATT 200,000 $2.3m0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
53 CONTEXT THERAPEUTICS INC COM CNTX CNTX 2,682,696 $1.5m0.04% 0.04% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.7m, Q2 2026 2.7m
54 EIKON THERAPEUTICS INC COM EIKN EIKN 37,902 $494.6k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 37.9k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
CENTESSA PHARMACEUTICALS PLC 4,286,480 $170.3m4.3m shares
FULCRUM THERAPEUTICS INC FULC FULC 5,250,000 $40.3m5.2m shares
LIQUIDIA CORPORATION LQDA LQDA 403,048 $15.2m403.0k shares
UROGEN PHARMA LTD URGN URGN 405,365 $7.3m405.4k shares
STRUCTURE THERAPEUTICS INC GPCR GPCR 140,411 $6.8m140.4k shares
UPSTREAM BIO INC UPB UPB 181,063 $1.6m181.1k shares
VISTAGEN THERAPEUTICS INC VTGN VTGN 2,676,580 $1.5m2.7m shares